bpc 157 with Wolverine Stack: Healing Faster Peptides BPC-157 for athletes and injury

Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500

Some of the human trials involved injecting the peptide under the skin (subcutaneously) and into the muscles (intramuscularly)

You do not have to anymore

Clinical Research Findings on AOD-9604 In clinical trials involving approximately 900 participants across six human studies, AOD-9604 demonstrated a favorable safety and tolerability profile

You deliver the injections in the fatty tissue just under the skin of your upper arm, in your abdomen, or thigh